Atlas Trials

Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid

Clinical trial NCT04128176 · WITHDRAWN

Trial details

NCT number
NCT04128176
Sponsor
University of California, Davis
Status
WITHDRAWN
Phase
Phase 3
Study type
INTERVENTIONAL
Bullous Pemphigoid
Start date
2017-03-01
Primary completion
2023-05-25
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.